GlassScriptPhysician profile
Dagmar Hernandez Suarez
NPI 1598178535
$23,120.11
in general payments reported to CMS, 2019-2025
26 companies · $197 in 2025
The $197 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,407 · 2020: $1,103 · 2021: $16K · 2022: $3,724 · 2023: $608 · 2024: $192 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $997.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $996.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16,820.05 | 2019-2024 | Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $1,935.51 | 2019-2025 | Watchman Flx, Avvigo Guidance System |
| Osprey Medical INC | $1,250.00 | 2022 | |
| Abbott Laboratories | $948.74 | 2019-2023 | Pressurewire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $344.58 | 2019-2021 | |
| Amgen INC. | $266.87 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $235.70 | 2019-2021 | |
| Abiomed | $175.90 | 2022-2025 | |
| Atricure, INC. | $166.00 | 2023 | |
| Cardiovascular Systems INC. | $120.20 | 2022 | |
| Pbg Puerto Rico LLC | $114.18 | 2019-2020 | |
| Shockwave Medical, INC | $113.60 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $80.20 | 2022-2023 | |
| Inari Medical, INC. | $71.23 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.16 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $68.98 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $61.31 | 2019-2020 | |
| Angiodynamics, INC. | $59.71 | 2025 | Alphavac |
| Chiesi USA, INC. | $50.66 | 2021-2022 | |
| Pfizer INC. | $46.79 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $22.30 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $21.76 | 2024 | Arcalyst |
| Pfizer Pharmaceuticals LLC | $20.08 | 2019 | |
| Heartflow, INC. | $19.85 | 2025 | |
| Akcea Therapeutics, INC. | $18.99 | 2019 | |
| Cordis US Corp. | $17.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dagmar Hernandez Suarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.